UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 20, 2023 4:01 P.M.
Form:
S-1
CIK:
0001636282
Company Name:
Aeglea BioTherapeutics, Inc.
File Number:
333-273769